Cargando…
128 Cure of HBV infection: can APOBEC3 deaminases mediate it?
Current antivirals cannot efficiently control but not eliminate hepatitis B virus (HBV) in the 300 million carriers at risk to develop liver diseases and cancer, because HBV establishes a stable nuclear cccDNA in infected hepatocytes. Interferon can clear HBV but therapeutic dosing is limited by sid...
Autor principal: | Protzer, Ulrike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149614/ http://dx.doi.org/10.1097/01.qai.0000446708.47107.00 |
Ejemplares similares
-
Human APOBEC1 cytidine deaminase edits HBV DNA
por: Gonzalez, Minerva Cervantes, et al.
Publicado: (2009) -
Genetic Editing of HBV DNA by Monodomain Human APOBEC3 Cytidine Deaminases and the Recombinant Nature of APOBEC3G
por: Henry, Michel, et al.
Publicado: (2009) -
Deaminase-Independent Inhibition of Parvoviruses by the APOBEC3A Cytidine Deaminase
por: Narvaiza, Iñigo, et al.
Publicado: (2009) -
AID/APOBEC deaminases and cancer
por: Rebhandl, Stefan, et al.
Publicado: (2015) -
Molecular targeting of mutagenic AID and APOBEC deaminases
por: Nabel, Christopher S, et al.
Publicado: (2014)